Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its insiders. Kura Oncology Inc shares valued at $231,931 were sold by Burrows Francis on Dec 18 ’25. At $9.78 per share, Burrows Francis sold 23,726 shares. The insider’s holdings dropped to 33,735 shares worth approximately $0.37 million following the completion of this transaction.
Also, FRANCIS J BURROWS purchased 23,726 shares, netting a total of over 231,934 in proceeds.
Before that, Hasnain Faheem had sold 10,000 shares from its account. In a trade valued at $109,764, the Director traded Kura Oncology Inc shares for $10.98 each. Upon closing the transaction, the insider’s holdings decreased to 10,000 shares, worth approximately $0.27 million.
As published in their initiating research note from Guggenheim on September 04, 2025, Kura Oncology Inc [KURA] has been a Neutral. Analysts at BTIG Research downgraded the stock from ‘”a Buy”‘ to ‘”a Neutral”‘ outlook in a report released in early February. As of October 24, 2024, UBS has initiated its “Buy” rating for KURA. Earlier on October 14, 2024, Stifel downgraded its rating. Their new recommendation was “a Hold” for KURA stock which previously was a “a Buy”.
Analyzing KURA Stock Performance
On last trading session, Kura Oncology Inc [NASDAQ: KURA] rose 2.50% to $11.06. The stock’s lowest price that day was $10.75, but it reached a high of $11.1199 in the same session. During the last five days, there has been a surge of approximately 8.64%. Over the course of the year, Kura Oncology Inc shares have jumped approximately 22.75%. Shares of the company reached a 52-week high of $12.49 on 11/14/25 and a 52-week low of $5.41 on 04/07/25.
Support And Resistance Levels for Kura Oncology Inc (KURA)
According to the 24-hour chart, there is a support level at 10.83, which, if violated, would cause prices to drop to 10.61. In the upper region, resistance lies at 11.20. The next price resistance is at 11.35. RSI (Relative Strength Index) is 52.90 on the 14-day chart, showing neutral technical sentiment.
Is Kura Oncology Inc subject to short interest?
Stocks of Kura Oncology Inc saw a sharp steep in short interest on 2025-12-15 dropping by -0.52 million shares to 8.22 million. Data from Yahoo Finance shows that the short interest on 2025-11-14 was 8.74 million shares. A decline of -6.34% in short interest reflects a positive sentiment towards the stock. Despite the fact that short shares comprise just 5.22 of the overall float, the days-to-cover ratio (short ratio) decline to 5.22.
Which companies own the most shares of Kura Oncology Inc (KURA)?
In terms of Kura Oncology Inc share price expectations, FactSet research, analysts set an average price target of 38 in the next 12 months, up nearly 252.18% from the previous closing price of $10.79. Analysts anticipate Kura Oncology Inc stock to reach 40 by 2025, with the lowest price target being 28. In spite of this, 3 analysts ranked Kura Oncology Inc stock as Buy at the end of 2025. On December 22, 2023, Mizuho assigned a price target of “a Buy” to the stock and initiated coverage with a $26.
